Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSIMERTINIB vs OSPHENA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSIMERTINIB vs OSPHENA: Safety Overview

Metric OSIMERTINIB OSPHENA
Total FAERS Reports 27,750 205
Deaths Reported 12,456 0
Death Rate 44.9% N/A
Hospitalizations 5,277 4
Average Patient Age 68.2 yrs 60.0 yrs
% Female Patients 66.0% N/A
FDA Approval Date Nov 13, 2015 N/A
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Prescription N/A